Discover
CSBR
Champions Oncology, Inc.
4.84
2 x 3.53
2 x 6.45
bid
ask
-
0.14
2.81%
2 @ 04:00 PM
4.93 +0.09 (1.86%)
| Ytd | -29.96% | |
| 1y | -26.22% |
4.84
day range
4.99
4.77
52 week range
7.80
| Open | 4.91 | Prev Close | 4.98 | Low | 4.84 | High | 4.99 | Mkt Cap | 67.37M |
| Vol | 1.87K | Avg Vol | 11.33K | EPS | -0.07 | P/E | N/A | Forward P/E | 42.68 |
| Beta | 0.49 | Short Ratio | 20.86 | Inst. Own | 49.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-10 | 50-d Avg | 5.07 | 200-d Avg | 5.91 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 15.23M | ||
| Revenues (USD) | 15.23M | ||
| Cost of Revenue | 7.53M | ||
| Gross Profit | 7.70M | ||
| Operating Expenses | 8.11M | ||
| Research and Development Expense | 2.34M | ||
| Selling, General and Administrative Expense | 5.76M | ||
| Operating Income | -409.00K | ||
| Income Tax Expense | 11.00K | ||
| Net Income | -426.00K | ||
| Net Income Common Stock | -426.00K | ||
| Net Income Common Stock (USD) | -426.00K | ||
| Consolidated Income | -426.00K | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -415.00K | ||
| Earning Before Interest & Taxes (USD) | -415.00K | ||
| Weighted Average Shares | 13.90M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.36M | ||
| Cash and Equivalents (USD) | 4.36M | ||
| Trade and Non-Trade Receivables | 13.60M | ||
| Current Assets | 19.29M | ||
| Property, Plant & Equipment Net | 13.46M | ||
| Total Assets | 33.29M | ||
| Debt Current | 635.00K | ||
| Total Debt | 10.52M | ||
| Current Liabilities | 18.73M | ||
| Debt Non-Current | 9.89M | ||
| Total Liabilities | 28.83M | ||
| Accumulated Retained Earnings (Deficit) | -81.49M | ||
| Shareholders Equity | 3.89M | ||
| Shareholders Equity (USD) | 3.89M | ||
| Assets Non-Current | 14.00M | ||
| Total Debt (USD) | 10.52M | ||
| Deferred Revenue | 9.55M | ||
| Goodwill and Intangible Assets | 335.00K | ||
| Liabilities Non-Current | 10.10M | ||
| Trade and Non-Trade Payables | 5.63M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 314.00K | ||
| Net Cash Flow from Financing | 33.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -514.00K | ||
| Capital Expenditure | -55.00K | ||
| Issuance (Purchase) of Equity Shares | 52.00K | ||
| Issuance (Repayment) of Debt Securities | -19.00K | ||
| Net Cash Flow from Investing | -55.00K | ||
| Net Cash Flow from Operations | -492.00K | ||
| Share Based Compensation | 766.00K | ||